OTCM
VRSEF
Market cap88kUSD
Jul 17, Last price
0.00USD
1D
0.00%
1Q
-60.34%
IPO
-87.43%
Name
Verisante Technology Inc
Chart & Performance
Profile
Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of innovative cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. The company was incorporated in 2006 and is based in Vancouver, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||
Revenues | ||||||
Cost of revenue | 128 | 288 | ||||
Unusual Expense (Income) | ||||||
NOPBT | (128) | (288) | ||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | (128) | (288) | ||||
Net income | (91) -107.53% | 1,202 -725.01% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 99 | |||||
BB yield | -55.28% | |||||
Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | 22 | 67 | ||||
Net debt | (30) | (86) | ||||
Cash flow | ||||||
Cash from operating activities | (111) | |||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | 55 | 129 | ||||
FCF | (128) | (288) | ||||
Balance | ||||||
Cash | 30 | 86 | ||||
Long term investments | ||||||
Excess cash | 30 | 86 | ||||
Stockholders' equity | (5,023) | (5,016) | ||||
Invested Capital | 5,033 | 5,078 | ||||
ROIC | ||||||
ROCE | ||||||
EV | ||||||
Common stock shares outstanding | 34,073 | 16,510 | ||||
Price | 0.01 | |||||
Market cap | 178 | |||||
EV | 93 | |||||
EBITDA | (128) | (288) | ||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT |